NCT00054015View on ClinicalTrials.gov

3-AP in Treating Patients With Advanced Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2002

Study Completion Date

January 31, 2008

Conditions
Prostate Cancer
Interventions
DRUG

triapine

Trial Locations (2)

94115

UCSF Comprehensive Cancer Center, San Francisco

33612-9497

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00054015 - 3-AP in Treating Patients With Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter